Impact of platelet to lymphocyte ratio and metabolic syndrome on the prognosis of colorectal cancer patients

References

• BrennerHKloorMPoxCPColorectal cancerLancet201438399271490150224225001
   PubMed Web of Science ®Google Scholar
• ChenWZhengRBaadePDCancer statistics in China, 2015CA Cancer J Clin201666211513226808342
   PubMed Web of Science ®Google Scholar
• MalikSWongNDFranklinSSImpact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adultsCirculation2004110101245125015326067
   PubMed Web of Science ®Google Scholar
• Expert panel on detection, evaluation, and treatment of high blood cholesterol in adultsExecutive summary of the third report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)JAMA2001285192486249711368702
   PubMed Web of Science ®Google Scholar
• AhmedRLSchmitzKHAndersonKERosamondWDFolsomARThe metabolic syndrome and risk of incident colorectal cancerCancer20061071283616721800
   PubMed Web of Science ®Google Scholar
• EspositoKChiodiniPColaoALenziAGiuglianoDMetabolic syndrome and risk of cancer: a systematic review and meta-analysisDiabetes Care201235112402241123093685
   PubMed Web of Science ®Google Scholar
• YangYMauldinPDEbelingMEffect of metabolic syndrome and its components on recurrence and survival in colon cancer patientsCancer201311981512152023280333
   PubMedGoogle Scholar
• StocksTLukanovaABjorgeTMetabolic factors and the risk of colorectal cancer in 580,000 men and women in the metabolic syndrome and cancer project (Me-Can)Cancer2011117112398240724048787
   PubMed Web of Science ®Google Scholar
• YouJLiuWYZhuGQMetabolic syndrome contributes to an increased recurrence risk of non-metastatic colorectal cancerOncotarget2015623198801989026082438
   PubMedGoogle Scholar
• PengFHuDLinXPreoperative metabolic syndrome and prognosis after radical resection for colorectal cancer: The Fujian prospective investigation of cancer (FIESTA) studyInt J Cancer2016139122705271327560834
   PubMedGoogle Scholar
• MaedaKShibutaniMOtaniHInflammation-based factors and prognosis in patients with colorectal cancerWorld J Gastrointest Oncol20157811111726306143
   PubMed Web of Science ®Google Scholar
• MantovaniAAllavenaPSicaABalkwillFCancer-related inflammationNature2008454720343644418650914
   PubMed Web of Science ®Google Scholar
• ColottaFAllavenaPSicaAGarlandaCMantovaniACancer-related inflammation, the seventh hallmark of cancer: links to genetic instabilityCarcinogenesis20093071073108119468060
   PubMed Web of Science ®Google Scholar
• Fernandez-RealJMRicartWInsulin resistance and chronic cardiovascular inflammatory syndromeEndocr Rev200324327830112788800
   PubMed Web of Science ®Google Scholar
• ShoelsonSELeeJGoldfineABInflammation and insulin resistanceJ Clin Invest200611671793180116823477
   PubMed Web of Science ®Google Scholar
• YouJZhuGQXieLPreoperative platelet to lymphocyte ratio is a valuable prognostic biomarker in patients with colorectal cancerOncotarget2016718255162552727027440
   PubMedGoogle Scholar
• TanDFuYSuQWangHPrognostic role of platelet-lymphocyte ratio in colorectal cancer: A systematic review and meta-analysisMedicine (Baltimore)20169524e383727310960
   PubMedGoogle Scholar
• SzkanderaJPichlerMAbsengerGThe elevated preoperative platelet to lymphocyte ratio predicts decreased time to recurrence in colon cancer patientsAm J Surg2014208221021424581872
   PubMed Web of Science ®Google Scholar
• FangKCChengYLSuCWHigher platelet counts are associated with metabolic syndrome independent of fatty liver diagnosisJ Chin Med Assoc201780312513227686501
   PubMed Web of Science ®Google Scholar
• ChenYLHungYJHeCTPlatelet count can predict metabolic syndrome in older womenPlatelets2015261313724512307
   PubMed Web of Science ®Google Scholar
• AkbogaMKCanpolatUYukselMPlatelet to lymphocyte ratio as a novel indicator of inflammation is correlated with the severity of metabolic syndrome: A single center large-scale studyPlatelets201627217818326196312
   PubMed Web of Science ®Google Scholar
• Chinese Metabolic Syndrome Study CooperationSuggestions about metabolic syndrome of Chinese diabetes societyChin J Diab200412156161
   Google Scholar
• EdgeSBComptonCCThe American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNMAnn Surg Oncol20101761471147420180029
   PubMed Web of Science ®Google Scholar
• O’NeillSBohlMGregersenSHermansenKO’DriscollLBlood-based biomarkers for metabolic syndromeTrends Endocrinol Metab201627636337427150849
   PubMed Web of Science ®Google Scholar
• WuSHLiuZHoSCMetabolic syndrome and all-cause mortality: a meta-analysis of prospective cohort studiesEur J Epidemiol201025637538420425137
   PubMed Web of Science ®Google Scholar
• ArbelYHavakukOHalkinARelation of metabolic syndrome with long-term mortality in acute and stable coronary diseaseAm J Cardiol2015115328328725499926
   PubMedGoogle Scholar
• JaggersJRSuiXHookerSPMetabolic syndrome and risk of cancer mortality in menEur J Cancer200945101831183819250819
   PubMed Web of Science ®Google Scholar
• IshinoKMutohMTotsukaYNakagamaHMetabolic syndrome: a novel high-risk state for colorectal cancerCancer Lett20133341566123085010
   PubMed Web of Science ®Google Scholar
• HirabaraSMGorjaoRVinoloMARodriguesACNachbarRTCuriRMolecular targets related to inflammation and insulin resistance and potential interventionsJ Biomed Biotechnol2012201237902423049242
   PubMedGoogle Scholar
• LiuJJDrutaMShibataDMetabolic syndrome and colorectal cancer: is hyperinsulinemia/insulin receptor-mediated angiogenesis a critical process?J Geriatr Oncol201451404824484717
   PubMedGoogle Scholar
• DespresJPAbdominal obesity and cardiovascular disease: is inflammation the missing link?Can J Cardiol201228664265222889821
   PubMed Web of Science ®Google Scholar
• KlotingNBluherMAdipocyte dysfunction, inflammation and metabolic syndromeRev Endocr Metab Disord201415427728725344447
   PubMed Web of Science ®Google Scholar
• Muller-EdenbornKLegerKGlaus GarzonJFHypoxia attenuates the proinflammatory response in colon cancer cells by regulating IkappaBOncotarget2015624202882030125978030
   PubMedGoogle Scholar
• MarianiFSenaPRoncucciLInflammatory pathways in the early steps of colorectal cancer developmentWorld J Gastroenterol201420299716973125110410
   PubMed Web of Science ®Google Scholar
• NielsenVGNfonsamVNMatikaRWColon and pancreas tumors enhance coagulation: role of hemeoxygenase-1Blood Coagul Fibrinolysis201425543543824509340
   PubMedGoogle Scholar
• LeeGHMalietzisGAskariAIs right-sided colon cancer different to left-sided colorectal cancer? – a systematic reviewEur J Surg Oncol201541330030825468456
   PubMed Web of Science ®Google Scholar
• BenedixFKubeRMeyerFComparison of 17,641 patients with right- and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survivalDis Colon Rectum2010531576420010352
   PubMed Web of Science ®Google Scholar
• MeguidRASlidellMBWolfgangCLChangDCAhujaNIs there a difference in survival between right- versus left-sided colon cancers?Ann Surg Oncol20081592388239418622647
   PubMed Web of Science ®Google Scholar
• IshizukaMNagataHTakagiKIwasakiYKubotaKPreoperative thrombocytosis is associated with survival after surgery for colorectal cancerJ Surg Oncol2012106788789122623286
   PubMed Web of Science ®Google Scholar
• SasakiKKawaiKTsunoNHSunamiEKitayamaJImpact of preoperative thrombocytosis on the survival of patients with primary colorectal cancerWorld J Surg201236119220022045447
   PubMed Web of Science ®Google Scholar
• van RooyMJPretoriusEMetabolic syndrome, platelet activation and the development of transient ischemic attack or thromboembolic strokeThromb Res2015135343444225601172
   PubMed Web of Science ®Google Scholar
• WangYYLinSYLiuPHCheungBMLaiWAAssociation between hematological parameters and metabolic syndrome components in a Chinese populationJ Diabetes Complications200418632232715531181
   PubMedGoogle Scholar
• LongYWangTGaoQZhouCPrognostic significance of pretreatment elevated platelet count in patients with colorectal cancer: a meta-analysisOncotarget2016749818498186127833087
   PubMedGoogle Scholar
• ZhaoJMWangYHYaoNPoor prognosis significance of pretreatment thrombocytosis in patients with colorectal cancer: a meta-analysisAsian Pac J Cancer Prev20161794295430027797233
   PubMedGoogle Scholar
• DunnGPOldLJSchreiberRDThe immunobiology of cancer immunosurveillance and immunoeditingImmunity200421213714815308095
   PubMed Web of Science ®Google Scholar
• WiesnerTBuglSMayerFHartmannJTKoppHGDifferential changes in platelet VEGF, Tsp, CXCL12, and CXCL4 in patients with metastatic cancerClin Exp Metastasis201027314114920182908
   PubMed Web of Science ®Google Scholar
• TanCEMaSWaiDChewSKTaiESCan we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians?Diabetes Care20042751182118615111542
   PubMed Web of Science ®Google Scholar
• XiBHeDHuYZhouDPrevalence of metabolic syndrome and its influencing factors among the Chinese adults: the China Health and Nutrition Survey in 2009Prev Med201357686787124103567
   PubMed Web of Science ®Google Scholar
• van DuijnhovenFJBueno-De-MesquitaHBCalligaroMBlood lipid and lipoprotein concentrations and colorectal cancer risk in the European Prospective Investigation into Cancer and NutritionGut20116081094110221383385
   PubMed Web of Science ®Google Scholar